“Classified research constitutes a much smaller portion of the U.S. biodefense program than many might suspect,” according to Gerald L. Epstein, a specialist at the Center for Strategic and International Studies.
“Nevertheless, classified DHS biodefense research will constitute one of the most controversial parts of the U.S. biodefense program,” he observed in Congressional testimony (pdf) earlier this month.
“Even more so than in other areas of science, the biological sciences have enjoyed a tradition of openness and international collaboration–and this heavy presumption of openness should continue. Since disease continues to kill millions of people around the world each year, any restrictions on relevant scientific knowledge could have serious consequences,” he told a House Science Subcommittee.
“Yet the existence of hostile, witting adversaries that are determined to wreak devastation and that are known to be interested in biological weapons mandates that this openness not be absolute.”
In March 8 testimony (at pp. 6-8), Dr. Epstein presented his views on how to reconcile these conflicting imperatives.
Researchers have many questions about the modernization of Pakistan’s nuclear-capable aircraft and associated air-launched cruise missiles.
The decision casts uncertainty on the role of scientific and technical expertise in federal decision-making, potentially harming our nation’s ability to respond effectively
Congress should foster a more responsive and evidence-based ecosystem for GenAI-powered educational tools, ensuring that they are equitable, effective, and safe for all students.
Without independent research, we do not know if the AI systems that are being deployed today are safe or if they pose widespread risks that have yet to be discovered, including risks to U.S. national security.